Rank | Gene Set | Z-score |
---|---|---|
1 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.48571380 |
2 | ER overload response (GO:0006983) | 4.03074118 |
3 | nuclear pore organization (GO:0006999) | 3.91340335 |
4 | cellular response to glucose starvation (GO:0042149) | 3.86122585 |
5 | response to peptidoglycan (GO:0032494) | 3.74792012 |
6 | negative regulation of thymocyte apoptotic process (GO:0070244) | 3.66128287 |
7 | germinal center formation (GO:0002467) | 3.61604866 |
8 | embryonic process involved in female pregnancy (GO:0060136) | 3.57658215 |
9 | growth hormone receptor signaling pathway (GO:0060396) | 3.56106602 |
10 | detection of other organism (GO:0098543) | 3.41740793 |
11 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.40715514 |
12 | regulation of oxidative stress-induced neuron death (GO:1903203) | 3.35055502 |
13 | nuclear pore complex assembly (GO:0051292) | 3.31808905 |
14 | cellular response to antibiotic (GO:0071236) | 3.31370106 |
15 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.28972843 |
16 | regulation of gene silencing by miRNA (GO:0060964) | 3.28972843 |
17 | regulation of gene silencing by RNA (GO:0060966) | 3.28972843 |
18 | cellular response to arsenic-containing substance (GO:0071243) | 3.23677384 |
19 | ribosomal small subunit assembly (GO:0000028) | 3.18264983 |
20 | response to muramyl dipeptide (GO:0032495) | 3.17496744 |
21 | cellular response to growth hormone stimulus (GO:0071378) | 3.13253008 |
22 | regulation of germinal center formation (GO:0002634) | 3.13191479 |
23 | COPII vesicle coating (GO:0048208) | 3.04110090 |
24 | neutrophil activation involved in immune response (GO:0002283) | 2.92896967 |
25 | detection of molecule of bacterial origin (GO:0032490) | 2.92512044 |
26 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.90745910 |
27 | definitive hemopoiesis (GO:0060216) | 2.89748794 |
28 | negative regulation of B cell apoptotic process (GO:0002903) | 2.89401271 |
29 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.88678092 |
30 | mRNA transcription from RNA polymerase II promoter (GO:0042789) | 2.86981259 |
31 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.86767847 |
32 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.86767847 |
33 | regulation of B cell apoptotic process (GO:0002902) | 2.83344672 |
34 | cellular extravasation (GO:0045123) | 2.82403868 |
35 | IMP biosynthetic process (GO:0006188) | 2.79653530 |
36 | cellular response to ethanol (GO:0071361) | 2.69328547 |
37 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.68733133 |
38 | nucleobase biosynthetic process (GO:0046112) | 2.68326815 |
39 | endothelial cell chemotaxis (GO:0035767) | 2.67961363 |
40 | purine nucleobase biosynthetic process (GO:0009113) | 2.67220616 |
41 | inositol phosphate catabolic process (GO:0071545) | 2.66351661 |
42 | negative regulation of interleukin-8 production (GO:0032717) | 2.66302016 |
43 | DNA replication checkpoint (GO:0000076) | 2.64631578 |
44 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.64483001 |
45 | detection of external biotic stimulus (GO:0098581) | 2.63737763 |
46 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.63370063 |
47 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.62788197 |
48 | positive regulation of leukocyte degranulation (GO:0043302) | 2.62053331 |
49 | pore complex assembly (GO:0046931) | 2.61824775 |
50 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.59609763 |
51 | hypotonic response (GO:0006971) | 2.58730138 |
52 | poly(A)+ mRNA export from nucleus (GO:0016973) | 2.57917457 |
53 | wound healing, spreading of epidermal cells (GO:0035313) | 2.57100411 |
54 | establishment of endothelial barrier (GO:0061028) | 2.56664683 |
55 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 2.56517685 |
56 | regulation of energy homeostasis (GO:2000505) | 2.56365012 |
57 | regulation of p38MAPK cascade (GO:1900744) | 2.56352548 |
58 | entrainment of circadian clock by photoperiod (GO:0043153) | 2.56160053 |
59 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.55531542 |
60 | positive regulation of mast cell degranulation (GO:0043306) | 2.54110309 |
61 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.54110309 |
62 | hemidesmosome assembly (GO:0031581) | 2.52711379 |
63 | positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO | 2.52286934 |
64 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151) | 2.52286934 |
65 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.51426228 |
66 | IMP metabolic process (GO:0046040) | 2.51191093 |
67 | protein K6-linked ubiquitination (GO:0085020) | 2.50956178 |
68 | metaphase plate congression (GO:0051310) | 2.50416769 |
69 | purine nucleotide salvage (GO:0032261) | 2.49555598 |
70 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.49290235 |
71 | megakaryocyte development (GO:0035855) | 2.47815093 |
72 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.47444027 |
73 | mitotic metaphase plate congression (GO:0007080) | 2.47192466 |
74 | COPI coating of Golgi vesicle (GO:0048205) | 2.46217621 |
75 | Golgi transport vesicle coating (GO:0048200) | 2.46217621 |
76 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.45821623 |
77 | maturation of SSU-rRNA (GO:0030490) | 2.45462235 |
78 | positive regulation of vasculogenesis (GO:2001214) | 2.45170016 |
79 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.45164971 |
80 | cellular response to gonadotropin stimulus (GO:0071371) | 2.44682538 |
81 | response to dsRNA (GO:0043331) | 2.44332294 |
82 | viral protein processing (GO:0019082) | 2.44145331 |
83 | positive regulation of glycolytic process (GO:0045821) | 2.44045991 |
84 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.43615702 |
85 | entrainment of circadian clock (GO:0009649) | 2.43210806 |
86 | platelet-derived growth factor receptor signaling pathway (GO:0048008) | 2.43028364 |
87 | regulation of cell proliferation involved in kidney development (GO:1901722) | 2.42922180 |
88 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.42848982 |
89 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.42691314 |
90 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.41966970 |
91 | negative regulation of acute inflammatory response (GO:0002674) | 2.41595075 |
92 | mRNA transcription (GO:0009299) | 2.37415056 |
93 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 2.37052807 |
94 | positive regulation of odontogenesis (GO:0042482) | 2.36942974 |
95 | purine-containing compound salvage (GO:0043101) | 2.35799640 |
96 | positive regulation of p38MAPK cascade (GO:1900745) | 2.35784122 |
97 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.33976305 |
98 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.33324553 |
99 | nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423) | 2.33186469 |
100 | response to progesterone (GO:0032570) | 2.32857171 |
101 | cellular response to fluid shear stress (GO:0071498) | 2.32813377 |
102 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.32536030 |
103 | histone mRNA catabolic process (GO:0071044) | 2.31755108 |
104 | negative regulation of complement activation (GO:0045916) | 2.31475872 |
105 | positive regulation of transforming growth factor beta production (GO:0071636) | 2.31007755 |
106 | formation of translation preinitiation complex (GO:0001731) | 2.30836026 |
107 | DNA replication initiation (GO:0006270) | 2.30404875 |
108 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.30364322 |
109 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.30222106 |
110 | protein K11-linked deubiquitination (GO:0035871) | 2.29878508 |
111 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.29801537 |
112 | response to hepatocyte growth factor (GO:0035728) | 2.29568685 |
113 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 2.29568685 |
114 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.29189509 |
115 | regulation of SMAD protein import into nucleus (GO:0060390) | 2.29184907 |
116 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.28746172 |
117 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.28746172 |
118 | intestinal epithelial cell development (GO:0060576) | 2.27726073 |
119 | histamine secretion (GO:0001821) | 2.27640242 |
120 | response to arsenic-containing substance (GO:0046685) | 2.26943784 |
121 | negative regulation of mast cell activation (GO:0033004) | 2.26122478 |
122 | oligosaccharide catabolic process (GO:0009313) | 2.25733538 |
123 | establishment of chromosome localization (GO:0051303) | 2.25471489 |
124 | B cell mediated immunity (GO:0019724) | 2.24924184 |
125 | positive regulation by symbiont of host defense response (GO:0052509) | 2.24135017 |
126 | modulation by symbiont of host defense response (GO:0052031) | 2.24135017 |
127 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.24135017 |
128 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.24135017 |
129 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.24135017 |
130 | modulation by symbiont of host immune response (GO:0052553) | 2.24135017 |
131 | positive regulation of epidermal cell differentiation (GO:0045606) | 2.23854325 |
132 | mitotic G2/M transition checkpoint (GO:0044818) | 2.23784906 |
133 | mitotic nuclear envelope disassembly (GO:0007077) | 2.23690288 |
134 | ribosome biogenesis (GO:0042254) | 2.23241688 |
135 | cellular response to interleukin-6 (GO:0071354) | 2.23239020 |
136 | histone H4-K12 acetylation (GO:0043983) | 2.22834286 |
137 | desmosome organization (GO:0002934) | 2.22637597 |
138 | hepatocyte apoptotic process (GO:0097284) | 2.22438640 |
139 | positive regulation of mast cell activation (GO:0033005) | 2.20980677 |
140 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.20476073 |
141 | establishment of skin barrier (GO:0061436) | 2.20292428 |
142 | ribosome assembly (GO:0042255) | 2.20193506 |
143 | positive regulation of autophagy (GO:0010508) | 2.20047294 |
144 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.19644801 |
145 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.19643680 |
146 | detection of biotic stimulus (GO:0009595) | 2.19497529 |
147 | detection of bacterium (GO:0016045) | 2.19087077 |
148 | mature B cell differentiation involved in immune response (GO:0002313) | 2.18924845 |
149 | RNA destabilization (GO:0050779) | 2.18734747 |
150 | regulation of T-helper cell differentiation (GO:0045622) | 2.17824103 |
151 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.17393165 |
152 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.17393165 |
153 | membrane budding (GO:0006900) | 2.17329013 |
154 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.16980585 |
155 | regulation of integrin activation (GO:0033623) | 2.16699276 |
156 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.16477823 |
157 | B cell differentiation (GO:0030183) | 2.16395772 |
158 | mitochondrial DNA replication (GO:0006264) | 2.16038414 |
159 | dosage compensation (GO:0007549) | 2.15983608 |
160 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.15371264 |
161 | inositol phosphate dephosphorylation (GO:0046855) | 2.15371264 |
162 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.15236745 |
163 | regulation of vitamin metabolic process (GO:0030656) | 2.15207628 |
164 | regulation of gene silencing (GO:0060968) | 2.14452864 |
165 | embryonic placenta development (GO:0001892) | 2.14363742 |
166 | transcytosis (GO:0045056) | 2.11175681 |
167 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.11079130 |
168 | regulation of mitotic spindle checkpoint (GO:1903504) | 2.10207642 |
169 | regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266) | 2.10207642 |
170 | regulation of interleukin-8 secretion (GO:2000482) | 2.09751663 |
171 | telomere maintenance via recombination (GO:0000722) | 2.09578881 |
172 | regulation of apoptotic cell clearance (GO:2000425) | 2.09453299 |
173 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.09337460 |
174 | immunoglobulin mediated immune response (GO:0016064) | 2.08791776 |
175 | positive regulation of interferon-beta production (GO:0032728) | 2.08770480 |
176 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.07950060 |
177 | membrane disassembly (GO:0030397) | 2.07575303 |
178 | nuclear envelope disassembly (GO:0051081) | 2.07575303 |
179 | peptide catabolic process (GO:0043171) | 2.06795618 |
180 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.06312228 |
181 | fibroblast migration (GO:0010761) | 2.06245797 |
182 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.04604178 |
183 | negative regulation of protein autophosphorylation (GO:0031953) | 2.04334722 |
184 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.03896597 |
185 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.03499716 |
186 | chromatin remodeling at centromere (GO:0031055) | 2.03383764 |
187 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.03364219 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.10534570 |
2 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.12765377 |
3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.93510700 |
4 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 3.42691205 |
5 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 3.42691205 |
6 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 3.42691205 |
7 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.92367665 |
8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.38724140 |
9 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.24131237 |
10 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.17117442 |
11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.12412235 |
12 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.12186691 |
13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.12147158 |
14 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.11972519 |
15 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.07583915 |
16 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 2.03848230 |
17 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.99629777 |
18 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.98149935 |
19 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.94207231 |
20 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.88093028 |
21 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.85803155 |
22 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.81919967 |
23 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.80318572 |
24 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.78619625 |
25 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.76438762 |
26 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.74559563 |
27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.73831326 |
28 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.72100557 |
29 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.71098233 |
30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.70801272 |
31 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.67921940 |
32 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.66753348 |
33 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.65016301 |
34 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64757487 |
35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.64501107 |
36 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.64262028 |
37 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.64084342 |
38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.63505072 |
39 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.59396324 |
40 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.58245447 |
41 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.57767244 |
42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.52149583 |
43 | * CJUN_26792858_Chip-Seq_BT549_Human | 1.52145894 |
44 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.51500355 |
45 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.51299392 |
46 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.50585873 |
47 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48059709 |
48 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.47813867 |
49 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.47717734 |
50 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.46713327 |
51 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.44258065 |
52 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43366346 |
53 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.43095959 |
54 | * MYB_26560356_Chip-Seq_TH2_Human | 1.41950109 |
55 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.40817386 |
56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.40337289 |
57 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.40083545 |
58 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.39743342 |
59 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.38054710 |
60 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.37645315 |
61 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.37645315 |
62 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.37131760 |
63 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.36884897 |
64 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.35536942 |
65 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34896210 |
66 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.31811609 |
67 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.31481986 |
68 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29049655 |
69 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28921689 |
70 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.28883963 |
71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.27811891 |
72 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.26194554 |
73 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.25399560 |
74 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.24539236 |
75 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.23658519 |
76 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.23014810 |
77 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.22417218 |
78 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.22327532 |
79 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.21810763 |
80 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.21721626 |
81 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.21321636 |
82 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.19659053 |
83 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.19269402 |
84 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.19254782 |
85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.19236963 |
86 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.18371982 |
87 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.17833405 |
88 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.17822946 |
89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.17417135 |
90 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.17037833 |
91 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.16478835 |
92 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.16374907 |
93 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.15547288 |
94 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15313854 |
95 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.14958020 |
96 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.14267088 |
97 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.13596515 |
98 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.13196374 |
99 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.12825739 |
100 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.12751077 |
101 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.12648632 |
102 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12603440 |
103 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12603440 |
104 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.12075654 |
105 | MYB_26560356_Chip-Seq_TH1_Human | 1.11559666 |
106 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10450542 |
107 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.09877140 |
108 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.09644348 |
109 | * FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.08274154 |
110 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 1.08208755 |
111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.07483366 |
112 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.07323663 |
113 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.07043734 |
114 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.04662676 |
115 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.04220156 |
116 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.04003214 |
117 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.03255350 |
118 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.02676479 |
119 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.02589939 |
120 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.01911602 |
121 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.01512447 |
122 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01317661 |
123 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.01182978 |
124 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01148360 |
125 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.01043739 |
126 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.99628072 |
127 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.98747424 |
128 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98385904 |
129 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98243265 |
130 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.97683046 |
131 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.97411759 |
132 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.97344109 |
133 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.97223101 |
134 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96880429 |
135 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.96750390 |
136 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.95176830 |
137 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.95157699 |
138 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95038718 |
139 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.94192284 |
140 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.94048517 |
141 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92812817 |
142 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.92739472 |
143 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92557713 |
144 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92466588 |
145 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.92349065 |
146 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.91815541 |
147 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.91747328 |
148 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.91313457 |
149 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.91307573 |
150 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.91185314 |
151 | * XRN2_22483619_ChIP-Seq_HELA_Human | 0.91152513 |
152 | * MYC_22102868_ChIP-Seq_BL_Human | 0.91022146 |
153 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.90990474 |
154 | GATA1_22025678_ChIP-Seq_K562_Human | 0.89473438 |
155 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.88726635 |
156 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.86405061 |
157 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.85771666 |
158 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.85677204 |
159 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85264520 |
160 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.84898400 |
161 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.84669156 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002138_abnormal_hepatobiliary_system | 3.29335118 |
2 | MP0002006_tumorigenesis | 2.68072033 |
3 | MP0002877_abnormal_melanocyte_morpholog | 2.65199296 |
4 | MP0003693_abnormal_embryo_hatching | 2.55447786 |
5 | MP0006054_spinal_hemorrhage | 2.52483855 |
6 | MP0003724_increased_susceptibility_to | 2.41686531 |
7 | MP0008007_abnormal_cellular_replicative | 2.27988362 |
8 | MP0000013_abnormal_adipose_tissue | 2.26151831 |
9 | MP0004957_abnormal_blastocyst_morpholog | 2.08961820 |
10 | MP0010094_abnormal_chromosome_stability | 2.02029976 |
11 | MP0010352_gastrointestinal_tract_polyps | 2.00302808 |
12 | MP0003941_abnormal_skin_development | 1.98585196 |
13 | MP0003656_abnormal_erythrocyte_physiolo | 1.91617216 |
14 | MP0003828_pulmonary_edema | 1.82329990 |
15 | MP0000685_abnormal_immune_system | 1.80741232 |
16 | MP0004264_abnormal_extraembryonic_tissu | 1.79027786 |
17 | MP0003566_abnormal_cell_adhesion | 1.78363532 |
18 | MP0004808_abnormal_hematopoietic_stem | 1.78257683 |
19 | MP0010368_abnormal_lymphatic_system | 1.75942239 |
20 | MP0003950_abnormal_plasma_membrane | 1.73973264 |
21 | MP0009278_abnormal_bone_marrow | 1.72643841 |
22 | MP0008057_abnormal_DNA_replication | 1.71914075 |
23 | MP0002009_preneoplasia | 1.65081670 |
24 | MP0003436_decreased_susceptibility_to | 1.63292821 |
25 | MP0003786_premature_aging | 1.62294508 |
26 | MP0000516_abnormal_urinary_system | 1.58347237 |
27 | MP0005367_renal/urinary_system_phenotyp | 1.58347237 |
28 | MP0010307_abnormal_tumor_latency | 1.57050359 |
29 | MP0003077_abnormal_cell_cycle | 1.56153489 |
30 | MP0005451_abnormal_body_composition | 1.55677753 |
31 | MP0010678_abnormal_skin_adnexa | 1.54253959 |
32 | MP0004782_abnormal_surfactant_physiolog | 1.51810482 |
33 | MP0004084_abnormal_cardiac_muscle | 1.50157856 |
34 | MP0002332_abnormal_exercise_endurance | 1.49050853 |
35 | MP0000490_abnormal_crypts_of | 1.46419529 |
36 | MP0005076_abnormal_cell_differentiation | 1.44695155 |
37 | MP0001545_abnormal_hematopoietic_system | 1.44535321 |
38 | MP0005397_hematopoietic_system_phenotyp | 1.44535321 |
39 | MP0003191_abnormal_cellular_cholesterol | 1.44143970 |
40 | MP0000465_gastrointestinal_hemorrhage | 1.43056748 |
41 | MP0002876_abnormal_thyroid_physiology | 1.42875864 |
42 | MP0001879_abnormal_lymphatic_vessel | 1.41569796 |
43 | MP0002132_abnormal_respiratory_system | 1.41517339 |
44 | MP0002060_abnormal_skin_morphology | 1.41314262 |
45 | MP0005023_abnormal_wound_healing | 1.40616903 |
46 | MP0008058_abnormal_DNA_repair | 1.39316170 |
47 | MP0004272_abnormal_basement_membrane | 1.37318194 |
48 | MP0009333_abnormal_splenocyte_physiolog | 1.34610041 |
49 | MP0001835_abnormal_antigen_presentation | 1.30411171 |
50 | MP0002396_abnormal_hematopoietic_system | 1.29511398 |
51 | MP0009697_abnormal_copulation | 1.23857199 |
52 | MP0003111_abnormal_nucleus_morphology | 1.23550454 |
53 | MP0000383_abnormal_hair_follicle | 1.23489920 |
54 | MP0002796_impaired_skin_barrier | 1.22781782 |
55 | MP0009764_decreased_sensitivity_to | 1.22615057 |
56 | MP0003448_altered_tumor_morphology | 1.20174004 |
57 | MP0010155_abnormal_intestine_physiology | 1.20068847 |
58 | MP0003279_aneurysm | 1.17390982 |
59 | MP0003705_abnormal_hypodermis_morpholog | 1.15962172 |
60 | MP0001533_abnormal_skeleton_physiology | 1.15730505 |
61 | MP0004883_abnormal_blood_vessel | 1.15369720 |
62 | MP0010234_abnormal_vibrissa_follicle | 1.15288818 |
63 | MP0005646_abnormal_pituitary_gland | 1.14912527 |
64 | MP0004036_abnormal_muscle_relaxation | 1.13017467 |
65 | MP0001853_heart_inflammation | 1.12937116 |
66 | MP0003300_gastrointestinal_ulcer | 1.12407315 |
67 | MP0000858_altered_metastatic_potential | 1.11960859 |
68 | MP0001873_stomach_inflammation | 1.09225229 |
69 | MP0002998_abnormal_bone_remodeling | 1.09202518 |
70 | MP0009840_abnormal_foam_cell | 1.07771734 |
71 | MP0001243_abnormal_dermal_layer | 1.07381142 |
72 | MP0003091_abnormal_cell_migration | 1.06308788 |
73 | MP0000767_abnormal_smooth_muscle | 1.06229837 |
74 | MP0002086_abnormal_extraembryonic_tissu | 1.06200941 |
75 | MP0005220_abnormal_exocrine_pancreas | 1.03193126 |
76 | MP0001800_abnormal_humoral_immune | 1.02984215 |
77 | MP0005275_abnormal_skin_tensile | 1.02650601 |
78 | MP0003075_altered_response_to | 1.01713275 |
79 | MP0001191_abnormal_skin_condition | 1.01704269 |
80 | MP0002405_respiratory_system_inflammati | 1.01013653 |
81 | MP0002419_abnormal_innate_immunity | 1.00841692 |
82 | MP0005501_abnormal_skin_physiology | 1.00762214 |
83 | MP0001216_abnormal_epidermal_layer | 1.00046144 |
84 | MP0000350_abnormal_cell_proliferation | 0.99559013 |
85 | MP0003453_abnormal_keratinocyte_physiol | 0.99502465 |
86 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99410366 |
87 | MP0008469_abnormal_protein_level | 0.99000544 |
88 | MP0002723_abnormal_immune_serum | 0.98550339 |
89 | MP0005390_skeleton_phenotype | 0.98338998 |
90 | MP0002971_abnormal_brown_adipose | 0.98018088 |
91 | MP0002254_reproductive_system_inflammat | 0.97972148 |
92 | MP0001915_intracranial_hemorrhage | 0.97822299 |
93 | MP0003195_calcinosis | 0.97678935 |
94 | MP0003567_abnormal_fetal_cardiomyocyte | 0.96706442 |
95 | MP0001790_abnormal_immune_system | 0.95013216 |
96 | MP0005387_immune_system_phenotype | 0.95013216 |
97 | MP0009379_abnormal_foot_pigmentation | 0.94664097 |
98 | MP0004947_skin_inflammation | 0.94232559 |
99 | MP0003943_abnormal_hepatobiliary_system | 0.93574375 |
100 | MP0009931_abnormal_skin_appearance | 0.91886226 |
101 | MP0005166_decreased_susceptibility_to | 0.91752815 |
102 | MP0005330_cardiomyopathy | 0.91022430 |
103 | MP0005535_abnormal_body_temperature | 0.89124561 |
104 | MP0000467_abnormal_esophagus_morphology | 0.88866656 |
105 | MP0001851_eye_inflammation | 0.88707058 |
106 | MP0002933_joint_inflammation | 0.88637643 |
107 | MP0003303_peritoneal_inflammation | 0.88633803 |
108 | MP0002148_abnormal_hypersensitivity_rea | 0.88610269 |
109 | MP0009780_abnormal_chondrocyte_physiolo | 0.88311690 |
110 | MP0005380_embryogenesis_phenotype | 0.88217959 |
111 | MP0001672_abnormal_embryogenesis/_devel | 0.88217959 |
112 | MP0002452_abnormal_antigen_presenting | 0.88163659 |
113 | MP0004484_altered_response_of | 0.88014323 |
114 | MP0000003_abnormal_adipose_tissue | 0.87135816 |
115 | MP0002019_abnormal_tumor_incidence | 0.86154052 |
116 | MP0003806_abnormal_nucleotide_metabolis | 0.85214505 |
117 | MP0002088_abnormal_embryonic_growth/wei | 0.84917953 |
118 | MP0001845_abnormal_inflammatory_respons | 0.84793139 |
119 | MP0002166_altered_tumor_susceptibility | 0.84787941 |
120 | MP0003984_embryonic_growth_retardation | 0.84759258 |
121 | MP0005464_abnormal_platelet_physiology | 0.84553972 |
122 | MP0005000_abnormal_immune_tolerance | 0.84320912 |
123 | MP0000689_abnormal_spleen_morphology | 0.84131132 |
124 | MP0000343_altered_response_to | 0.83226365 |
125 | MP0002127_abnormal_cardiovascular_syste | 0.82489155 |
126 | MP0005165_increased_susceptibility_to | 0.81741515 |
127 | MP0002693_abnormal_pancreas_physiology | 0.81494377 |
128 | MP0005164_abnormal_response_to | 0.81387599 |
129 | MP0005671_abnormal_response_to | 0.81086085 |
130 | MP0003763_abnormal_thymus_physiology | 0.80731497 |
131 | MP0008995_early_reproductive_senescence | 0.79787214 |
132 | MP0002722_abnormal_immune_system | 0.79287726 |
133 | MP0009785_altered_susceptibility_to | 0.79032617 |
134 | MP0005084_abnormal_gallbladder_morpholo | 0.78388609 |
135 | MP0004197_abnormal_fetal_growth/weight/ | 0.78112563 |
136 | MP0002420_abnormal_adaptive_immunity | 0.77769831 |
137 | MP0002398_abnormal_bone_marrow | 0.77190585 |
138 | MP0005508_abnormal_skeleton_morphology | 0.76854255 |
139 | MP0008004_abnormal_stomach_pH | 0.76709659 |
140 | MP0000249_abnormal_blood_vessel | 0.76636865 |
141 | MP0005025_abnormal_response_to | 0.76276611 |
142 | MP0001819_abnormal_immune_cell | 0.76238710 |
143 | * MP0001542_abnormal_bone_strength | 0.76060146 |
144 | MP0002972_abnormal_cardiac_muscle | 0.73582341 |
145 | MP0008875_abnormal_xenobiotic_pharmacok | 0.73455691 |
146 | MP0001727_abnormal_embryo_implantation | 0.72630607 |
147 | MP0000716_abnormal_immune_system | 0.72214633 |
Rank | Gene Set | Z-score |
---|---|---|
1 | B lymphocytopenia (HP:0010976) | 4.88946250 |
2 | Abnormality of B cell number (HP:0010975) | 4.71596140 |
3 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.03240430 |
4 | Panhypogammaglobulinemia (HP:0003139) | 3.81108894 |
5 | Nemaline bodies (HP:0003798) | 3.79069131 |
6 | Muscle fiber inclusion bodies (HP:0100299) | 3.69989537 |
7 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.58564632 |
8 | Metaphyseal dysplasia (HP:0100255) | 3.46499352 |
9 | Agnosia (HP:0010524) | 3.44538914 |
10 | Hypoproteinemia (HP:0003075) | 3.42697261 |
11 | Distal lower limb muscle weakness (HP:0009053) | 3.26458501 |
12 | Muscle fiber splitting (HP:0003555) | 3.18873320 |
13 | Eosinophilia (HP:0001880) | 2.97573201 |
14 | Exocrine pancreatic insufficiency (HP:0001738) | 2.95251277 |
15 | 11 pairs of ribs (HP:0000878) | 2.84258488 |
16 | Stridor (HP:0010307) | 2.80002880 |
17 | Granulocytopenia (HP:0001913) | 2.75279090 |
18 | Thyroiditis (HP:0100646) | 2.75229240 |
19 | Nonimmune hydrops fetalis (HP:0001790) | 2.73524997 |
20 | Cervical subluxation (HP:0003308) | 2.73245031 |
21 | Diaphragmatic weakness (HP:0009113) | 2.72129908 |
22 | Birth length less than 3rd percentile (HP:0003561) | 2.69975554 |
23 | Fatigue (HP:0012378) | 2.65453307 |
24 | Rimmed vacuoles (HP:0003805) | 2.57747122 |
25 | Agammaglobulinemia (HP:0004432) | 2.56203137 |
26 | Orchitis (HP:0100796) | 2.54940680 |
27 | Severe combined immunodeficiency (HP:0004430) | 2.53092770 |
28 | Exercise-induced myalgia (HP:0003738) | 2.52311104 |
29 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.51901011 |
30 | Vertebral hypoplasia (HP:0008417) | 2.48910043 |
31 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 2.48910043 |
32 | Erythroderma (HP:0001019) | 2.48394800 |
33 | Chromsome breakage (HP:0040012) | 2.43204557 |
34 | Missing ribs (HP:0000921) | 2.40981198 |
35 | Myositis (HP:0100614) | 2.38814830 |
36 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.38520069 |
37 | Limb-girdle muscle atrophy (HP:0003797) | 2.33109537 |
38 | Increased CSF protein (HP:0002922) | 2.32579121 |
39 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.31100335 |
40 | Cone-rod dystrophy (HP:0000548) | 2.30614129 |
41 | Myelodysplasia (HP:0002863) | 2.29777588 |
42 | Thrombocytosis (HP:0001894) | 2.24991641 |
43 | Long clavicles (HP:0000890) | 2.24566211 |
44 | Rhabdomyolysis (HP:0003201) | 2.23652212 |
45 | Type I transferrin isoform profile (HP:0003642) | 2.22607153 |
46 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.20320968 |
47 | Subaortic stenosis (HP:0001682) | 2.20320968 |
48 | Vacuolated lymphocytes (HP:0001922) | 2.16986398 |
49 | Myoglobinuria (HP:0002913) | 2.16570246 |
50 | Popliteal pterygium (HP:0009756) | 2.14521906 |
51 | Vascular calcification (HP:0004934) | 2.12769357 |
52 | Increased IgE level (HP:0003212) | 2.12307252 |
53 | Abnormal biliary tract morphology (HP:0012440) | 2.12246358 |
54 | Metaphyseal cupping (HP:0003021) | 2.11258480 |
55 | Symptomatic seizures (HP:0011145) | 2.11198899 |
56 | Testicular neoplasm (HP:0010788) | 2.10696576 |
57 | Hyperglycemia (HP:0003074) | 2.10503083 |
58 | Recurrent viral infections (HP:0004429) | 2.09721573 |
59 | Milia (HP:0001056) | 2.09476808 |
60 | Chronic sinusitis (HP:0011109) | 2.09412286 |
61 | Tongue fasciculations (HP:0001308) | 2.08731408 |
62 | Amyloidosis (HP:0011034) | 2.08545176 |
63 | Short nail (HP:0001799) | 2.08312700 |
64 | Hypoplasia of the thymus (HP:0000778) | 2.07734614 |
65 | Erythema (HP:0010783) | 2.07032695 |
66 | Alveolar cell carcinoma (HP:0006519) | 2.06714534 |
67 | Plantar hyperkeratosis (HP:0007556) | 2.06514206 |
68 | Submucous cleft hard palate (HP:0000176) | 2.06492687 |
69 | Basal ganglia calcification (HP:0002135) | 2.06094603 |
70 | Hypoplasia of the odontoid process (HP:0003311) | 2.05782525 |
71 | Stomatitis (HP:0010280) | 2.05091477 |
72 | Myocardial infarction (HP:0001658) | 2.04783945 |
73 | EMG: myopathic abnormalities (HP:0003458) | 2.04735100 |
74 | Keratoconjunctivitis sicca (HP:0001097) | 2.03500671 |
75 | Palmoplantar hyperkeratosis (HP:0000972) | 2.01290958 |
76 | Gastrointestinal atresia (HP:0002589) | 1.99630833 |
77 | Right ventricular cardiomyopathy (HP:0011663) | 1.99405388 |
78 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.97080317 |
79 | Abnormal spermatogenesis (HP:0008669) | 1.96322670 |
80 | Abnormality of the anterior horn cell (HP:0006802) | 1.94782392 |
81 | Degeneration of anterior horn cells (HP:0002398) | 1.94782392 |
82 | Xerostomia (HP:0000217) | 1.94473992 |
83 | Systemic lupus erythematosus (HP:0002725) | 1.94300241 |
84 | Congenital, generalized hypertrichosis (HP:0004540) | 1.94186624 |
85 | Increased cerebral lipofuscin (HP:0011813) | 1.93672985 |
86 | Recurrent abscess formation (HP:0002722) | 1.93671203 |
87 | Onycholysis (HP:0001806) | 1.93637718 |
88 | Steatorrhea (HP:0002570) | 1.93469754 |
89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.93372466 |
90 | Muscle fibrillation (HP:0010546) | 1.93155406 |
91 | Recurrent fungal infections (HP:0002841) | 1.92839682 |
92 | Meckel diverticulum (HP:0002245) | 1.92130703 |
93 | Spinal muscular atrophy (HP:0007269) | 1.92041560 |
94 | Autoimmune hemolytic anemia (HP:0001890) | 1.90704872 |
95 | Aplastic anemia (HP:0001915) | 1.90216279 |
96 | Azoospermia (HP:0000027) | 1.90185274 |
97 | Facial diplegia (HP:0001349) | 1.89996075 |
98 | Abnormality of eosinophils (HP:0001879) | 1.89986177 |
99 | Carpal bone hypoplasia (HP:0001498) | 1.89743680 |
100 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.89709793 |
101 | Cardiovascular calcification (HP:0011915) | 1.89385484 |
102 | Abnormality of chromosome stability (HP:0003220) | 1.89013821 |
103 | Decreased skull ossification (HP:0004331) | 1.88440378 |
104 | Intestinal atresia (HP:0011100) | 1.87873567 |
105 | Absent thumb (HP:0009777) | 1.87795986 |
106 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.87563920 |
107 | Vertebral compression fractures (HP:0002953) | 1.87455667 |
108 | Tubulointerstitial nephritis (HP:0001970) | 1.86456769 |
109 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.85964180 |
110 | Urethral obstruction (HP:0000796) | 1.85865673 |
111 | Lip pit (HP:0100267) | 1.85758856 |
112 | Neonatal respiratory distress (HP:0002643) | 1.84518991 |
113 | Palmar hyperkeratosis (HP:0010765) | 1.84445237 |
114 | Distal lower limb amyotrophy (HP:0008944) | 1.83791234 |
115 | Leukocytosis (HP:0001974) | 1.83731863 |
116 | Gonadal dysgenesis (HP:0000133) | 1.82428452 |
117 | Upper motor neuron abnormality (HP:0002127) | 1.82380630 |
118 | Stomach cancer (HP:0012126) | 1.81754221 |
119 | Type 1 muscle fiber predominance (HP:0003803) | 1.81709846 |
120 | Anhidrosis (HP:0000970) | 1.81549009 |
121 | Neck muscle weakness (HP:0000467) | 1.81333692 |
122 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.81075799 |
123 | Abnormality of skull ossification (HP:0002703) | 1.80401667 |
124 | Atrophic scars (HP:0001075) | 1.80333680 |
125 | Abnormality of the nasal septum (HP:0000419) | 1.80047589 |
126 | Supernumerary spleens (HP:0009799) | 1.79740586 |
127 | Absent frontal sinuses (HP:0002688) | 1.79271281 |
128 | Keratoconjunctivitis (HP:0001096) | 1.78728238 |
129 | Cone-shaped epiphyses of the phalanges of the hand (HP:0010230) | 1.78237771 |
130 | Hypoglycemic seizures (HP:0002173) | 1.77964490 |
131 | Abnormality of the ileum (HP:0001549) | 1.77653617 |
132 | Breast hypoplasia (HP:0003187) | 1.77278763 |
133 | Optic neuritis (HP:0100653) | 1.77103328 |
134 | Retrobulbar optic neuritis (HP:0100654) | 1.77103328 |
135 | Meningitis (HP:0001287) | 1.76545266 |
136 | Syringomyelia (HP:0003396) | 1.76359856 |
137 | Spinal cord lesions (HP:0100561) | 1.76359856 |
138 | Thick nail (HP:0001805) | 1.75896432 |
139 | Barrel-shaped chest (HP:0001552) | 1.75223433 |
140 | Stillbirth (HP:0003826) | 1.74921861 |
141 | Reticulocytopenia (HP:0001896) | 1.74813805 |
142 | Fetal akinesia sequence (HP:0001989) | 1.74787431 |
143 | Mitral stenosis (HP:0001718) | 1.74565524 |
144 | Esophageal varix (HP:0002040) | 1.74020322 |
145 | Hypothermia (HP:0002045) | 1.73014539 |
146 | Constricted visual fields (HP:0001133) | 1.72544105 |
147 | Eczematoid dermatitis (HP:0000976) | 1.72542721 |
148 | Mesomelia (HP:0003027) | 1.72477553 |
149 | Ankle contracture (HP:0006466) | 1.72220928 |
150 | Widely spaced teeth (HP:0000687) | 1.71890006 |
151 | Beaking of vertebral bodies (HP:0004568) | 1.71636080 |
152 | Prostate neoplasm (HP:0100787) | 1.71380339 |
153 | Abnormality of the calf musculature (HP:0001430) | 1.70967940 |
154 | Curly hair (HP:0002212) | 1.69882537 |
155 | Dry hair (HP:0011359) | 1.69252459 |
156 | Amaurosis fugax (HP:0100576) | 1.69222559 |
157 | Esophageal atresia (HP:0002032) | 1.68907748 |
158 | Microvesicular hepatic steatosis (HP:0001414) | 1.68360447 |
159 | Menstrual irregularities (HP:0000858) | 1.67442039 |
160 | Spondylolisthesis (HP:0003302) | 1.67129629 |
161 | Tetraparesis (HP:0002273) | 1.65953790 |
162 | Small intestinal stenosis (HP:0012848) | 1.65887632 |
163 | Duodenal stenosis (HP:0100867) | 1.65887632 |
164 | Trismus (HP:0000211) | 1.65745035 |
165 | Deep philtrum (HP:0002002) | 1.65548218 |
166 | Acute myeloid leukemia (HP:0004808) | 1.65501776 |
167 | Growth hormone excess (HP:0000845) | 1.65417794 |
168 | Gowers sign (HP:0003391) | 1.65407633 |
169 | Combined immunodeficiency (HP:0005387) | 1.65253431 |
170 | Exercise-induced muscle cramps (HP:0003710) | 1.64878008 |
171 | Pruritus (HP:0000989) | 1.64791474 |
172 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.63975738 |
173 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.63624512 |
174 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.63624512 |
175 | Abnormality of glycolipid metabolism (HP:0010969) | 1.63624512 |
176 | Hematochezia (HP:0002573) | 1.62838341 |
177 | Abnormality of the preputium (HP:0100587) | 1.62482034 |
178 | Glossoptosis (HP:0000162) | 1.62079806 |
179 | Flat capital femoral epiphysis (HP:0003370) | 1.60923174 |
180 | Arterial thrombosis (HP:0004420) | 1.60830162 |
181 | Abnormal hemoglobin (HP:0011902) | 1.60790909 |
182 | Portal hypertension (HP:0001409) | 1.60720334 |
183 | Alopecia of scalp (HP:0002293) | 1.60673613 |
184 | Increased mean platelet volume (HP:0011877) | 1.60200616 |
185 | Abnormality of the duodenum (HP:0002246) | 1.59918170 |
186 | Irregular epiphyses (HP:0010582) | 1.59274608 |
187 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.57830484 |
188 | Anorexia (HP:0002039) | 1.57757708 |
189 | Abnormality of the calcaneus (HP:0008364) | 1.57725815 |
190 | Abnormality of the frontal sinuses (HP:0002687) | 1.57590982 |
191 | Spontaneous hematomas (HP:0007420) | 1.57373079 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA2 | 3.44584651 |
2 | AKT3 | 3.29768576 |
3 | ZAK | 2.71518419 |
4 | TGFBR2 | 2.52413487 |
5 | TSSK6 | 2.34410335 |
6 | MAP3K14 | 2.29865082 |
7 | BRSK2 | 2.26337671 |
8 | MAP3K2 | 2.19651034 |
9 | TGFBR1 | 2.18476905 |
10 | FRK | 2.16734047 |
11 | TIE1 | 2.15056976 |
12 | ACVR1B | 2.13736454 |
13 | MAP3K3 | 2.10032938 |
14 | WEE1 | 2.01229445 |
15 | IRAK1 | 2.00559320 |
16 | TAOK3 | 1.97837523 |
17 | TBK1 | 1.90354346 |
18 | MAP3K12 | 1.88409168 |
19 | PIM2 | 1.86642234 |
20 | CDK12 | 1.86531742 |
21 | MAP3K6 | 1.81368737 |
22 | MET | 1.68649187 |
23 | PASK | 1.59174689 |
24 | RPS6KB2 | 1.56998941 |
25 | OBSCN | 1.55537404 |
26 | STK10 | 1.53137670 |
27 | ERN1 | 1.52719360 |
28 | STK3 | 1.49917405 |
29 | PIM1 | 1.49694275 |
30 | MAP3K13 | 1.46454833 |
31 | CASK | 1.45185279 |
32 | PDK2 | 1.38258849 |
33 | IRAK2 | 1.34084841 |
34 | CDC7 | 1.33035906 |
35 | CDK8 | 1.31910520 |
36 | MAP2K3 | 1.31592351 |
37 | MAP3K7 | 1.27455415 |
38 | PLK3 | 1.25932507 |
39 | CHUK | 1.23164271 |
40 | RPS6KA4 | 1.21273914 |
41 | NLK | 1.19827005 |
42 | MAPK15 | 1.19598475 |
43 | KDR | 1.17726651 |
44 | MST1R | 1.16175174 |
45 | SIK3 | 1.15484856 |
46 | MST4 | 1.13724189 |
47 | TXK | 1.11318764 |
48 | TRPM7 | 1.09318126 |
49 | BUB1 | 1.08999517 |
50 | IKBKB | 1.07392623 |
51 | ERBB3 | 1.01604197 |
52 | HIPK2 | 1.00849478 |
53 | MAP3K1 | 1.00554229 |
54 | MAPK7 | 0.99768702 |
55 | BRD4 | 0.99332620 |
56 | MAPKAPK3 | 0.99301375 |
57 | CSF1R | 0.98131316 |
58 | EIF2AK3 | 0.97059127 |
59 | VRK1 | 0.93875082 |
60 | CDK7 | 0.93212327 |
61 | CDK6 | 0.92993515 |
62 | MAP3K5 | 0.92970557 |
63 | ERBB4 | 0.91347401 |
64 | TEC | 0.89058725 |
65 | TTK | 0.88164441 |
66 | MKNK2 | 0.87152878 |
67 | GRK7 | 0.86646785 |
68 | CSK | 0.86270233 |
69 | SCYL2 | 0.85663931 |
70 | IKBKE | 0.85459338 |
71 | FLT3 | 0.85282441 |
72 | BMPR2 | 0.85108911 |
73 | NEK2 | 0.85065275 |
74 | STK24 | 0.84550731 |
75 | PLK1 | 0.83510585 |
76 | MAP2K2 | 0.80559729 |
77 | GRK1 | 0.79420996 |
78 | MKNK1 | 0.79104368 |
79 | LATS1 | 0.78699475 |
80 | CCNB1 | 0.76665570 |
81 | IRAK4 | 0.76632467 |
82 | GSK3A | 0.74223907 |
83 | EIF2AK2 | 0.73305426 |
84 | CDK9 | 0.72393068 |
85 | PRKG2 | 0.72254813 |
86 | PIK3CG | 0.71843964 |
87 | NEK9 | 0.70586703 |
88 | ADRBK2 | 0.68751919 |
89 | PAK4 | 0.68613372 |
90 | AURKB | 0.68247004 |
91 | YES1 | 0.67824849 |
92 | NME2 | 0.67637524 |
93 | EPHA3 | 0.67379256 |
94 | PRPF4B | 0.67108253 |
95 | EPHB1 | 0.66617855 |
96 | EEF2K | 0.66265667 |
97 | TAOK2 | 0.65639499 |
98 | JAK3 | 0.65218862 |
99 | MAP4K1 | 0.64221021 |
100 | TTN | 0.64153242 |
101 | ABL2 | 0.64091700 |
102 | EIF2AK1 | 0.62001477 |
103 | KIT | 0.61967835 |
104 | TAF1 | 0.61409570 |
105 | STK38L | 0.61207454 |
106 | FER | 0.59708477 |
107 | IRAK3 | 0.59509980 |
108 | PLK2 | 0.58223325 |
109 | BCR | 0.57766583 |
110 | MYLK | 0.57311536 |
111 | CHEK2 | 0.56414376 |
112 | STK4 | 0.56215186 |
113 | MATK | 0.56156413 |
114 | PHKG2 | 0.55827104 |
115 | PHKG1 | 0.55827104 |
116 | RPS6KA5 | 0.55485600 |
117 | JAK1 | 0.53057064 |
118 | FGFR3 | 0.52307399 |
119 | ZAP70 | 0.50656438 |
120 | RPS6KA6 | 0.50438131 |
121 | BRAF | 0.48663066 |
122 | MAPK12 | 0.48344192 |
123 | MAPKAPK2 | 0.48342960 |
124 | BRSK1 | 0.47392086 |
125 | MAP2K4 | 0.46833170 |
126 | INSRR | 0.46464749 |
127 | MAPK11 | 0.46051945 |
128 | SGK2 | 0.45440196 |
129 | MAP2K6 | 0.44691289 |
130 | MOS | 0.44386258 |
131 | GRK6 | 0.43801298 |
132 | ABL1 | 0.43413704 |
133 | ATR | 0.42774921 |
134 | CLK1 | 0.42774897 |
135 | MAPK3 | 0.42642114 |
136 | RPS6KA1 | 0.42244651 |
137 | MAP2K1 | 0.41990428 |
138 | ATM | 0.40928472 |
139 | DAPK1 | 0.40397403 |
140 | PRKAA2 | 0.39817646 |
141 | MAPK4 | 0.38537537 |
142 | MAP4K2 | 0.38392698 |
143 | TYK2 | 0.37167426 |
144 | HCK | 0.35580760 |
145 | STK39 | 0.35240019 |
146 | MAPK1 | 0.33335588 |
147 | TRIM28 | 0.30529260 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.93944680 |
2 | Circadian rhythm_Homo sapiens_hsa04710 | 2.71027345 |
3 | Mismatch repair_Homo sapiens_hsa03430 | 2.65928962 |
4 | DNA replication_Homo sapiens_hsa03030 | 2.61219792 |
5 | Asthma_Homo sapiens_hsa05310 | 2.53904642 |
6 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.23479723 |
7 | Cell cycle_Homo sapiens_hsa04110 | 2.08100428 |
8 | Legionellosis_Homo sapiens_hsa05134 | 2.03930265 |
9 | Allograft rejection_Homo sapiens_hsa05330 | 2.01384809 |
10 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.99449384 |
11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.96162229 |
12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.85572169 |
13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.79841918 |
14 | Homologous recombination_Homo sapiens_hsa03440 | 1.78315890 |
15 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.77871143 |
16 | Base excision repair_Homo sapiens_hsa03410 | 1.75900252 |
17 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.73530837 |
18 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.73358629 |
19 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.72104162 |
20 | Thyroid cancer_Homo sapiens_hsa05216 | 1.65420311 |
21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.64614172 |
22 | RNA degradation_Homo sapiens_hsa03018 | 1.64433551 |
23 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.62705346 |
24 | RNA transport_Homo sapiens_hsa03013 | 1.60492276 |
25 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.54705320 |
26 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.52755320 |
27 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.52111611 |
28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.49197152 |
29 | Adherens junction_Homo sapiens_hsa04520 | 1.47879167 |
30 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.44491869 |
31 | Protein export_Homo sapiens_hsa03060 | 1.42447467 |
32 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.37195216 |
33 | Spliceosome_Homo sapiens_hsa03040 | 1.35365680 |
34 | RNA polymerase_Homo sapiens_hsa03020 | 1.34329621 |
35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.34302494 |
36 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33857671 |
37 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.33507661 |
38 | Pertussis_Homo sapiens_hsa05133 | 1.32703179 |
39 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32586032 |
40 | Basal transcription factors_Homo sapiens_hsa03022 | 1.32200437 |
41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.30473589 |
42 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.28528781 |
43 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.26965319 |
44 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.22621740 |
45 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.22546213 |
46 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.17782322 |
47 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.17688413 |
48 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.17246818 |
49 | Ribosome_Homo sapiens_hsa03010 | 1.16557717 |
50 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.14587222 |
51 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.13624079 |
52 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.12705946 |
53 | Proteasome_Homo sapiens_hsa03050 | 1.12531189 |
54 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.10771423 |
55 | Shigellosis_Homo sapiens_hsa05131 | 1.09446599 |
56 | Apoptosis_Homo sapiens_hsa04210 | 1.08249467 |
57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07947550 |
58 | Malaria_Homo sapiens_hsa05144 | 1.07382085 |
59 | Insulin resistance_Homo sapiens_hsa04931 | 1.06537618 |
60 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.05031170 |
61 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.03237880 |
62 | Viral myocarditis_Homo sapiens_hsa05416 | 1.01566013 |
63 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98542511 |
64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.98048178 |
65 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.97168762 |
66 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.96929373 |
67 | Galactose metabolism_Homo sapiens_hsa00052 | 0.96727680 |
68 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.96271943 |
69 | Influenza A_Homo sapiens_hsa05164 | 0.95863385 |
70 | Platelet activation_Homo sapiens_hsa04611 | 0.95036276 |
71 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93479664 |
72 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92686463 |
73 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89627606 |
74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89591002 |
75 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.89330288 |
76 | Hepatitis B_Homo sapiens_hsa05161 | 0.89286829 |
77 | Phagosome_Homo sapiens_hsa04145 | 0.88847617 |
78 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.88500494 |
79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.88290118 |
80 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.87976265 |
81 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86056080 |
82 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.85114190 |
83 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.85024908 |
84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.84151062 |
85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.83455015 |
86 | Measles_Homo sapiens_hsa05162 | 0.83299931 |
87 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.82091509 |
88 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.79078423 |
89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.77864918 |
90 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.74550577 |
91 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.73364414 |
92 | Tuberculosis_Homo sapiens_hsa05152 | 0.72971171 |
93 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72529266 |
94 | Bladder cancer_Homo sapiens_hsa05219 | 0.71364949 |
95 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70298716 |
96 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.70153041 |
97 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.69236509 |
98 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.68460287 |
99 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.68323175 |
100 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.67689794 |
101 | Hepatitis C_Homo sapiens_hsa05160 | 0.64960071 |
102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63057780 |
103 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.63049662 |
104 | Focal adhesion_Homo sapiens_hsa04510 | 0.62653808 |
105 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.61188745 |
106 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.61009820 |
107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60583157 |
108 | Prostate cancer_Homo sapiens_hsa05215 | 0.59991495 |
109 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.59772816 |
110 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58951969 |
111 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.58356382 |
112 | Purine metabolism_Homo sapiens_hsa00230 | 0.57589746 |
113 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.57501073 |
114 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.57388959 |
115 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57122660 |
116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.56836682 |
117 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.56772889 |
118 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.56726906 |
119 | Salmonella infection_Homo sapiens_hsa05132 | 0.56590471 |
120 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55935724 |
121 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.55035668 |
122 | Long-term depression_Homo sapiens_hsa04730 | 0.54968759 |
123 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.52700096 |
124 | Pathways in cancer_Homo sapiens_hsa05200 | 0.50510970 |
125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.50174017 |
126 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49266349 |
127 | Amoebiasis_Homo sapiens_hsa05146 | 0.48680108 |
128 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.48390962 |
129 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.47828655 |
130 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.47761011 |
131 | Lysosome_Homo sapiens_hsa04142 | 0.47391095 |
132 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46774427 |
133 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46523861 |
134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.45327530 |
135 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43817413 |
136 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.43467153 |
137 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42704790 |
138 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.41492509 |
139 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.36826964 |
140 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.36304430 |
141 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.34903913 |